Quick Comparison
| Feature | Retatrutide | Semaglutide |
|---|---|---|
| Weight Loss | 24-28.7% Winner | 10-15% |
| Mechanism | Triple agonist (GLP-1/GIP/Glucagon) | Single agonist (GLP-1) |
| Availability | 2027-2028 (Phase 3) | Available Now |
| Cost (Compounded) | $300-600/mo (unknown) | $179-349/mo |
| Track Record | Clinical trials only | 5+ years real-world |
Weight Loss Results: The Numbers
Retatrutide: 24-28.7% Weight Loss
Phase 3 trials show retatrutide delivers up to 28.7% average weight loss (71.2 lbs for a 240-lb person). The triple-receptor mechanism (GLP-1 + GIP + glucagon) drives significantly more fat loss than single-agonist medications.
Semaglutide: 10-15% Weight Loss
Semaglutide (Wegovy/Ozempic) delivers 14.9% average weight loss at the 2.4mg weekly dose. While less than retatrutide, it's proven effective with millions of real-world success stories and 5+ years of safety data.
How They Work: Mechanism Comparison
Retatrutide's Triple Action
- GLP-1 activation: Reduces appetite, slows digestion
- GIP activation: Improves insulin response, fat metabolism
- Glucagon activation: Boosts metabolic rate, burns stored fat
Semaglutide's Single Action
- GLP-1 activation only: Suppresses hunger, delays gastric emptying
- Proven mechanism that works well for most people
- Simpler = potentially fewer side effects for some
Side Effects: What to Expect
Both medications share similar GI side effects due to GLP-1 receptor activation:
- Nausea (most common, usually temporary)
- Diarrhea or constipation
- Vomiting
- Reduced appetite
Key difference: Retatrutide's triple-agonist mechanism hasn't shown significantly worse side effects in trials, but it has less real-world safety data than semaglutide's 5+ years of use.
Cost Comparison
Semaglutide (Available Now)
- Brand-name (Wegovy): $900-1,400/month
- Compounded: $179-349/month through telemedicine
- Most affordable option currently available
Retatrutide (When Available 2027-2028)
- Expected brand pricing: $900-1,400/month
- Compounded (if allowed): $300-600/month estimate
- Insurance unlikely to cover (like current GLP-1s)
Which Should You Choose?
Choose Retatrutide If:
- You can wait 1-2 years for FDA approval
- You need maximum weight loss (75+ pounds to lose)
- You've tried semaglutide and plateaued
- Cost isn't a primary concern
Choose Semaglutide If:
- You want to start losing weight NOW
- You want the most affordable option ($179-349/month)
- You prefer the longest safety track record (5+ years)
- You need 25-40 pounds of weight loss
The Practical Answer: Start Semaglutide Now
Why wait 1-2 years? Start semaglutide TODAY through telemedicine providers, lose 30-40 pounds, then switch to retatrutide when it's approved if you want even better results. You'll be healthier NOW instead of waiting until 2028.
Start Semaglutide Today for $179/Month
Available now through telemedicine. No insurance needed. Ships in 3-5 days.
Related: Retatrutide vs Tirzepatide Comparison | What Is Retatrutide?